These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20025128)

  • 21. Zonisamide: a new drug for Parkinson's disease.
    Murata M
    Drugs Today (Barc); 2010 Apr; 46(4):251-8. PubMed ID: 20502722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retention rate of zonisamide in intractable epilepsy.
    Nakken KO; Lindstrøm P; Andersen H
    Acta Neurol Scand; 2015 May; 131(5):268-74. PubMed ID: 25644477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zonisamide: aspects in neuroprotection.
    Rösler TW; Arias-Carrión O; Höglinger GU
    Exp Neurol; 2010 Aug; 224(2):336-9. PubMed ID: 20450911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term retention rate of zonisamide in patients with epilepsy: an observational study.
    Kim DW; Choi K; Moon HS; Oh J
    Clin Neuropharmacol; 2014; 37(5):133-5. PubMed ID: 25229169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of Japanese experience-controlled and uncontrolled trials.
    Yagi K
    Seizure; 2004 Dec; 13 Suppl 1():S11-5; discussion S16. PubMed ID: 15511680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zonisamide: its pharmacology, efficacy and safety in clinical trials.
    Brodie MJ; Ben-Menachem E; Chouette I; Giorgi L
    Acta Neurol Scand Suppl; 2012; (194):19-28. PubMed ID: 23106522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report.
    Maschio M; Dinapoli L; Saveriano F; Pompili A; Carapella CM; Vidiri A; Jandolo B
    Acta Neurol Scand; 2009 Sep; 120(3):210-2. PubMed ID: 19719809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy, tolerability, and retention rates of zonisamide in older adult patients with focal-onset epilepsy: Experiences from two tertiary epilepsy centers.
    Doğan EA; Genç E; Genç BO; Erdoğan Ç
    Epilepsy Behav; 2017 Nov; 76():19-23. PubMed ID: 28927711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zonisamide in the management of epilepsy--Japanese experience.
    Ohtahara S
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zonisamide in pediatric epilepsy: review of the Japanese experience.
    Glauser TA; Pellock JM
    J Child Neurol; 2002 Feb; 17(2):87-96. PubMed ID: 11952083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy.
    Peters DH; Sorkin EM
    Drugs; 1993 May; 45(5):760-87. PubMed ID: 7686468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zonisamide: new drug. No advantage in refractory partial epilepsy.
    Prescrire Int; 2007 Jun; 16(89):95-7. PubMed ID: 17582922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Newer antiepileptic drugs].
    Matsuura M
    No To Shinkei; 2007 Feb; 59(2):147-56. PubMed ID: 17315756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy.
    Johannessen Landmark C
    CNS Drugs; 2008; 22(1):27-47. PubMed ID: 18072813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical efficacy of zonisamide in Lennox-Gastaut syndrome: Korean multicentric experience.
    You SJ; Kang HC; Kim HD; Lee HS; Ko TS
    Brain Dev; 2008 Apr; 30(4):287-90. PubMed ID: 17959327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy.
    Marinas A; Villanueva V; Giráldez BG; Molins A; Salas-Puig J; Serratosa JM
    Epileptic Disord; 2009 Mar; 11(1):61-6. PubMed ID: 19264587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective effects of zonisamide target astrocyte.
    Asanuma M; Miyazaki I; Diaz-Corrales FJ; Kimoto N; Kikkawa Y; Takeshima M; Miyoshi K; Murata M
    Ann Neurol; 2010 Feb; 67(2):239-49. PubMed ID: 20225289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lamotrigine and its applications in the treatment of epilepsy and other neurological and psychiatric disorders.
    Malik S; Arif H; Hirsch LJ
    Expert Rev Neurother; 2006 Nov; 6(11):1609-27. PubMed ID: 17144777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy.
    Kondo T; Kaneko S; Amano Y; Egawa I
    Epilepsia; 1996 Dec; 37(12):1242-4. PubMed ID: 8956859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.